anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 22,111-22,140
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

22,111-22,140 of 26,550

filter-aware
23
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
24
Includes a map of Turkey, a bar chart comparing gaming spend as % of GDP, and two bar charts showing growth in turnover and online stake penetration.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
Includes Sustainalytics ranking as a validation metric.Flutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
26
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
27
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
28
Flutter | Investor Presentation Deck | 28 slidesFlutter | Investor Presentation Deck | 28 slides · Flutter Entertainment
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
01
Slide 1
Includes company logo, tagline, and date.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
02
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
03
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
04
The slide uses a three-column layout to highlight key value propositions of the Olvi-Vec technology.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to show clinical trial stages for multiple drug candidates.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
Uses a process diagram to illustrate the transition from cold to hot tumor states via viral infection.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The central diagram shows a biological mechanism comparing 'Absence of Effector T Cells' (Platinum resistant) vs 'Presence of Effector T Cells' (Platinum sensitive).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
The slide uses a timeline to establish market maturity and investor confidence.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a list-based comparison and a logo-grid to frame the competitive landscape.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a pyramid diagram to represent the evolution of oncolytic virus technology, with Genelux's platform at the top.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a document-style callout for key takeaways and a vertical icon-list for clinical data points.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide uses a process-flow layout to show the trial design and its validation through publications and follow-up trials.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
Data table presents ORR, Duration of Response, CA-125 response, PFS, and OS across patient subgroups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
Waterfall plot and spider plot showing patient-level clinical outcomes.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a series of bar charts to compare PFS across multiple treatment regimens for three specific patients (15B-01, 15B-15, 15B-17).Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
Kaplan-Meier survival curve showing superior performance of VIRO-15 compared to historical 4th line treatment data.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
The chart compares cross-trial data; the footnote explicitly warns against direct comparison due to protocol differences.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) as evidence of efficacy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
Includes a bio for Benny Li, PhD, CEO of Newsoara.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide highlights a strategic partnership, funding, and commercial rights split between US and Greater China markets.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide highlights a combination therapy approach involving oncolytic immunotherapy and adoptive cell therapy.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
24
The slide uses a map of the US as a background to anchor the market sizing to a specific geography.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit